Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological basis for chemo-radiotherapy interactions.

C Hennequin1, V Favaudon

  • 1Service de Cancérologie-Radiothérapie, Hôpital Saint-Louis, 1 avenue Claude Vellefeaux, 75010 Paris, France. christophe.hennequin@sls.ap-hop-paris.fr

European Journal of Cancer (Oxford, England : 1990)
|January 23, 2002
PubMed
Summary

Chemo-radiotherapy combinations enhance cancer treatment by exploiting molecular, cellular, and tissue-level interactions. Understanding these mechanisms improves therapeutic strategies for epithelial tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Informed consent in radiotherapy care].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024
Same author

[Antimicrobial peptides: A new alternative for the treatment of aspergillosis].

Revue des maladies respiratoires·2024
Same author

Withdrawal notice to "Changes in the fungal nomenclature: why and how to manage?" [J Mycol Med 33 (2023) 101387].

Journal de mycologie medicale·2023
Same author

[Targeted systemic treatments and locoregional radiotherapy for breast cancer: Can we expect a benefit from the potentiation of local treatment?]

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2023

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Chemo-radiotherapy is a standard treatment for locally advanced epithelial tumors.
  • The efficacy of combined modalities relies on synergistic interactions.
  • These interactions occur at molecular, cellular, and tissue levels.

Purpose of the Study:

  • To describe the mechanisms of interaction between radiation and chemotherapeutic agents.
  • To elucidate how these interactions enhance treatment outcomes.
  • To explore future therapeutic strategies for improving the therapeutic index.

Main Methods:

  • Review of existing literature on chemo-radiotherapy mechanisms.
  • Description of molecular interactions (e.g., DNA repair).

Related Experiment Videos

  • Analysis of cellular interactions (e.g., cell cycle effects).
  • Examination of tissue-level interactions (e.g., reoxygenation, drug uptake).

    • Main Results:

    • Chemo-radiotherapy combinations demonstrate synergistic effects through various interaction mechanisms.
    • Specific agents like cis-diammino-platinum (II) (cis-Pt), 5-fluoro-2'-deoxyuridine (5-FU), taxanes, and gemcitabine exhibit distinct interactions with radiation.
    • Paclitaxel-induced radiosensitization is mediated by cell synchronization and reoxygenation.

    Conclusions:

    • Understanding the interplay between chemotherapy and radiation is crucial for optimizing treatment.
    • Targeted therapies, such as epidermal growth factor receptor (EGFR) inhibitors and angiogenesis inhibitors, hold promise for enhancing the therapeutic index.
    • Future research should focus on integrating targeted agents with chemo-radiotherapy to improve patient outcomes.